search
Back to results

Bile Aspiration vs Drain in Acute Cholecystitis

Primary Purpose

Cholecystitis, Acute

Status
Not yet recruiting
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Gallbladder aspiration
Cholecystostomy
Sponsored by
Karolinska Institutet
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cholecystitis, Acute

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Acute cholecystitis, not warranting acute cholecystectomy

Exclusion Criteria:

  • Indication for acute cholecystectomy, i.e. history < 5 days and no contraindication to surgery
  • Liver cirrhosis
  • Ascites
  • Emphysematous cholecystitis
  • Gallbladder perforation
  • Suspected malignant condition
  • Portal Hypertension
  • Biliary pancreatitis
  • Common bile duct stones

Sites / Locations

  • Karolinska University Hospital, Center for Digestive Diseases

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Cholecystostomy

Gallbladder aspiration

Arm Description

Percutaneous cholecystostomy, leaving drain in situ

Gallblader aspiration without drain

Outcomes

Primary Outcome Measures

Amount of morphine administrated
The total amount of morphine required to relieve the pain the first 24 hours

Secondary Outcome Measures

Pain
Pain intensity rated on a Visual Analogue Scale
Nausea
Nausea estimated with a Likert scale
Re-intervention
Repeated percutaneous aspiration of adjustment of drain
Body temperature
Temperature measured daily
CRP
Daily measures of C-reactive protein
LPK
Daily measures of Leukocyte particle Concentration
Time to discharge
Time from intervention to discharge from the hospital
Complications
Procedure-related complications

Full Information

First Posted
January 4, 2017
Last Updated
March 1, 2023
Sponsor
Karolinska Institutet
search

1. Study Identification

Unique Protocol Identification Number
NCT03012243
Brief Title
Bile Aspiration vs Drain in Acute Cholecystitis
Official Title
Randomized Controlled Trial of Bile Aspiration vs Drain in Acute Cholecystitis
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
August 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2023 (Anticipated)
Study Completion Date
August 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In order to compare percutaneous cholecystostomy and leaving a drain in situ with percutaneous gallbladder aspiration we plan to undertake a double-blind randomized controlled trial.
Detailed Description
Percutaneous cholecystostomy is a minimally invasive technique for treatment of cholecystitis. The cholecystostomy can be inserted transhepatically or transabdominally. The transhepatic route is preferred due to lower risk for bile leakage. The drainage decompresses the gallbladder and drains the bile. This decompression reduces the inflammatory process in the gallbladder. Percutaneous cholecystostomy is often applied in patients not fit for emergency surgery who are in need of intervention due to deterioration of their clinical status. However, even though cholecystostomy is widely practised, it is not fully evaluated. Percutaneous cholecystostomy has a high success rate, a low procedure-related mortality but a 30 day mortality of 15%. Furthermore, recurrence rates within one year after a cholecystostomy are reported to range between 4 to 22%. The time duration of the drainage differ between different studies and range from three to six weeks. Optimal timing for drainage has not been studied. Two weeks seem to be sufficient for a maturation of the tract for the transhepatic route and 3 weeks for the transabdominal route. It has been suggested that a prolonged drainage duration is associated with increased risk for recurrence of inflammation due to local irritation of the gallbladder mucosa by the drain. Percutaneous cholecystostomy is often considered as a bridge to surgery. However, less than half of patients treated with PC are treated with cholecystectomy. This suggests that this treatment is often chosen in a group not fit for surgery and often turns out to be a definitive treatment. Percutaneous gallbladder aspiration is a technique used for purposes similar to percutaneous cholecystostomy. This technique is an alternative that may be more convenient than percutaneous cholecystostomy. The aspiration is performed with a small gauge needle under ultrasound guidance without leaving a drain. The aspiration leads to a decompression of the gallbladder, which facilitates recovery. However, it has only been described in a few studies and need more evaluation. One single aspiration may be sufficient to relief symptoms for the majority of patients, but if two aspirations are performed the success rate increases substantially. One randomized controlled trial has been presented where PC is compared to gallbladder aspiration. In this trial PC was superior to gallbladder aspiration in terms of effectiveness. In this trail, however, only one aspiration was performed. No major complications occurred in either group and minor complications were equal between the groups. In a retrospective study comparing aspiration with PC it was found that gallbladder aspiration is safer than PC and has a comparable clinical outcome. It is believed that single decompressions are sufficient for reduction of the intraluminal pressure. Only a minority of patients have positive bile cultures which, indicates that infection is not a key mechanism in development of cholecystitis, which indicates that a continuous drainage may not be necessary. As lower rates of complications are reported for aspiration due to usage of smaller needle and no drain left that can dislocate and cause bile leakage which is feared complication of PC. It is suggested that PC can have a role as a salvage method when aspiration is not successful. In order to compare percutaneous cholecystostomy and leaving a drain in situ with percutaneous gallbladder aspiration we plan to undertake a double-blind randomized controlled trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholecystitis, Acute

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cholecystostomy
Arm Type
Active Comparator
Arm Description
Percutaneous cholecystostomy, leaving drain in situ
Arm Title
Gallbladder aspiration
Arm Type
Experimental
Arm Description
Gallblader aspiration without drain
Intervention Type
Procedure
Intervention Name(s)
Gallbladder aspiration
Other Intervention Name(s)
Percutaneous intervention
Intervention Description
Percutaneous ultrasound-guided aspiration of bile from the gallbladder. This is performed without leaving a drain in the gallbladder. The aspiration is performed with the intention to relief the pressure in the gallbladder, without drain.
Intervention Type
Procedure
Intervention Name(s)
Cholecystostomy
Other Intervention Name(s)
Percutaneous intervention
Intervention Description
Ultrasound-guided insertion of drain in the gallbladder. The drain is left in the gallbladder until clinical assessment and laboratory analyses show that the acute cholecystitis has been successfully treated.
Primary Outcome Measure Information:
Title
Amount of morphine administrated
Description
The total amount of morphine required to relieve the pain the first 24 hours
Time Frame
24 hours
Secondary Outcome Measure Information:
Title
Pain
Description
Pain intensity rated on a Visual Analogue Scale
Time Frame
5 days
Title
Nausea
Description
Nausea estimated with a Likert scale
Time Frame
5 days
Title
Re-intervention
Description
Repeated percutaneous aspiration of adjustment of drain
Time Frame
5 days
Title
Body temperature
Description
Temperature measured daily
Time Frame
5 days
Title
CRP
Description
Daily measures of C-reactive protein
Time Frame
5 days
Title
LPK
Description
Daily measures of Leukocyte particle Concentration
Time Frame
5 days
Title
Time to discharge
Description
Time from intervention to discharge from the hospital
Time Frame
30 days
Title
Complications
Description
Procedure-related complications
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Acute cholecystitis, not warranting acute cholecystectomy Exclusion Criteria: Indication for acute cholecystectomy, i.e. history < 5 days and no contraindication to surgery Liver cirrhosis Ascites Emphysematous cholecystitis Gallbladder perforation Suspected malignant condition Portal Hypertension Biliary pancreatitis Common bile duct stones
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Agnieszka Popowicz, MD
Phone
+46 73 582 62 13
Email
a.e.popowicz@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Gabriel Sandblom, Assoc Prof
Phone
+46 70 415 82 18
Email
gabriel.sandblom@ki.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gabriel Sandblom, Assoc Prof
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Karolinska University Hospital, Center for Digestive Diseases
City
Stockholm
ZIP/Postal Code
14186
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Bile Aspiration vs Drain in Acute Cholecystitis

We'll reach out to this number within 24 hrs